L & S Advisors’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.88M | Sell |
4,734
-2,577
| -35% | -$1.13M | 0.19% | 129 |
|
|
2026
Q1 | $3.37M | Sell |
7,311
-1,105
| -13% | -$559K | 0.42% | 73 |
|
|
2025
Q4 | $4.77M | Buy |
8,416
+82
| +1% | +$43.7K | 0.44% | 67 |
|
|
2025
Q3 | $3.73M | Buy |
8,334
+357
| +4% | +$171K | 0.36% | 72 |
|
|
2025
Q2 | $4.34M | Sell |
7,977
-8,198
| -51% | -$4.29M | 0.43% | 66 |
|
|
2025
Q1 | $8.01M | Sell |
16,175
-5,848
| -27% | -$3.23M | 0.99% | 22 |
|
|
2024
Q4 | $11.5M | Sell |
22,023
-404
| -2% | -$210K | 1.26% | 11 |
|
|
2024
Q3 | $11M | Buy |
22,427
+7,362
| +49% | +$3.43M | 1.15% | 16 |
|
|
2024
Q2 | $6.7M | Sell |
15,065
-1,734
| -10% | -$691K | 0.76% | 34 |
|
|
2024
Q1 | $6.7M | Buy |
16,799
+8,166
| +95% | +$3.09M | 0.76% | 35 |
|
|
2023
Q4 | $2.91M | Sell |
8,633
-1,366
| -14% | -$407K | 0.35% | 77 |
|
|
2023
Q3 | $2.92M | Sell |
9,999
-1,570
| -14% | -$490K | 0.42% | 62 |
|
|
2023
Q2 | $3.96M | Sell |
11,569
-2,607
| -18% | -$789K | 0.53% | 58 |
|
|
2023
Q1 | $3.62M | Sell |
14,176
-504
| -3% | -$124K | 0.51% | 58 |
|
|
2022
Q4 | $3.9M | Sell |
14,680
-726
| -5% | -$177K | 0.72% | 46 |
|
|
2022
Q3 | $2.89M | Sell |
15,406
-224
| -1% | -$48.1K | 0.51% | 50 |
|
|
2022
Q2 | $3.14M | Sell |
15,630
-1,931
| -11% | -$453K | 0.52% | 48 |
|
|
2022
Q1 | $5.3M | Sell |
17,561
-5,882
| -25% | -$1.72M | 0.63% | 53 |
|
|
2021
Q4 | $8.42M | Buy |
23,443
+52
| +0.2% | +$17.9K | 0.91% | 29 |
|
|
2021
Q3 | $7.75M | Buy |
23,391
+1,026
| +5% | +$345K | 0.84% | 28 |
|
|
2021
Q2 | $6.86M | Buy |
22,365
+5,559
| +33% | +$1.56M | 0.74% | 30 |
|
|
2021
Q1 | $4.14M | Sell |
16,806
-5,997
| -26% | -$1.51M | 0.47% | 70 |
|
|
2020
Q4 | $6.22M | Buy |
22,803
+1,122
| +5% | +$279K | 0.72% | 34 |
|
|
2020
Q3 | $5.13M | Sell |
21,681
-888
| -4% | -$199K | 0.71% | 39 |
|
|
2020
Q2 | $4.29M | Buy |
22,569
+84
| +0.4% | +$15.1K | 0.64% | 47 |
|
|
2020
Q1 | $3.71M | Sell |
22,485
-477
| -2% | -$87.4K | 0.7% | 31 |
|
|
2019
Q4 | $4.53M | Sell |
22,962
-2,016
| -8% | -$377K | 0.58% | 44 |
|
|
2019
Q3 | $4.5M | Buy |
24,978
+1,185
| +5% | +$205K | 0.63% | 47 |
|
|
2019
Q2 | $4.16M | Sell |
23,793
-1,035
| -4% | -$177K | 0.55% | 47 |
|
|
2019
Q1 | $4.72M | Buy |
24,828
+1,002
| +4% | +$178K | 0.64% | 46 |
|
|
2018
Q4 | $3.8M | Buy |
23,826
+582
| +3% | +$98.6K | 0.71% | 30 |
|
|
2018
Q3 | $4.45M | Buy |
23,244
+264
| +1% | +$46.9K | 0.58% | 55 |
|
|
2018
Q2 | $3.67M | Buy |
22,980
+318
| +1% | +$48.5K | 0.62% | 50 |
|
|
2018
Q1 | $3.12M | Sell |
22,662
-960
| -4% | -$134K | 0.59% | 50 |
|
|
2017
Q4 | $2.87M | Sell |
23,622
-1,218
| -5% | -$152K | 0.44% | 68 |
|
|
2017
Q3 | $2.89M | Buy |
24,840
+2,970
| +14% | +$324K | 0.48% | 64 |
|
|
2017
Q2 | $2.27M | Buy |
21,870
+3,870
| +22% | +$372K | 0.4% | 79 |
|
|
2017
Q1 | $1.53M | Hold |
18,000
| – | – | 0.29% | 95 |
|
|
2016
Q4 | $1.27M | Buy |
+18,000
| New | +$1.32M | 0.29% | 82 |
|
Other funds holding ISRG
L & S Advisors's ISRG Position: Q2 2026 in Review
L & S Advisors reduced its Intuitive Surgical (ISRG) stake by 35% in Q2 2026, selling an estimated $1.13M and leaving 4,734 shares worth $1.88M. The position accounts for 0.19% of the portfolio, ranked #129.
L & S Advisors first reported a position in ISRG in Q4 2016 and has held it in 39 quarters since. The position peaked at $11.5M in Q4 2024. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.
- L & S Advisors held 4,734 shares of Intuitive Surgical worth $1.88M as of Q2 2026.
- L & S Advisors sold 2,577 Intuitive Surgical shares in Q2 2026, an estimated $1.13M.
- Intuitive Surgical made up 0.19% of L & S Advisors's portfolio in Q2 2026, its #129 holding.
- L & S Advisors first reported a position in Intuitive Surgical in Q4 2016 and has held it in 39 quarters since.
- L & S Advisors's Intuitive Surgical position peaked at $11.5M in Q4 2024.
- 2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.
Based on L & S Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.